{"abstract": "The drug maker plans to pay Daniel Vasella, its departing chairman, $78 million to prevent him from sharing knowledge with competitors.", "web_url": "https://www.nytimes.com/2013/02/19/business/global/for-daniel-vasella-of-novartis-78-million-to-keep-secrets.html", "snippet": "The drug maker plans to pay Daniel Vasella, its departing chairman, $78 million to prevent him from sharing knowledge with competitors.", "lead_paragraph": "LONDON \u2014 A plan by Novartis, one of Switzerland\u2019s biggest drug makers, to pay its departing chairman $78 million to keep him from sharing his knowledge with competitors has added fuel to an already heated debate about executive pay.", "print_section": "B", "print_page": "3", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2013/02/19/business/19novartis-web/19novartis-web-articleLarge.jpg", "height": 314, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2013/02/19/business/19novartis-web/19novartis-web-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 314}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2013/02/19/business/19novartis-web/19novartis-web-jumbo.jpg", "height": 536, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2013/02/19/business/19novartis-web/19novartis-web-superJumbo.jpg", "height": 1072, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2013/02/19/business/19novartis-web/19novartis-web-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2013/02/19/business/19novartis-web/19novartis-web-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2013/02/19/business/19novartis-web/19novartis-web-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": " Critics of Executive Pay Put Pressure on Novartis ", "kicker": null, "content_kicker": null, "print_headline": "Critics of Executive Pay Put Pressure on Novartis", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "persons", "value": "Werdigier, Julia", "rank": 1, "major": "N"}, {"name": "subject", "value": "Executive Compensation", "rank": 2, "major": "N"}, {"name": "subject", "value": "Wages and Salaries", "rank": 3, "major": "N"}, {"name": "persons", "value": "Vasella, Daniel L", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Novartis AG", "rank": 5, "major": "N"}], "pub_date": "2013-02-18T19:49:46+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "subsection_name": "Global Business", "byline": {"original": "By Julia Werdigier", "person": [{"firstname": "Julia", "middlename": null, "lastname": "Werdigier", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/6685428a-1770-5036-9544-3d1ecd137f54", "word_count": 509, "uri": "nyt://article/6685428a-1770-5036-9544-3d1ecd137f54"}